Drug Profile
BY 170424
Alternative Names: BY 424Latest Information Update: 02 Apr 2008
Price :
$50
*
At a glance
- Originator Nycomed
- Class Antiulcers
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 02 Apr 2008 Discontinued - Preclinical for Helicobacter infections in Europe (unspecified route)
- 02 Apr 2008 Discontinued - Preclinical for Helicobacter infections in USA (unspecified route)
- 22 Aug 2002 Preclinical trials in Helicobacter infections in Europe (unspecified route)